News Agencies Feed :


    October 20, 2020

    COVID-19 Vaccine: Morocco Negotiating Purchases With 3 Firms

    Rabat – Head of Government Saad Eddine El Othmani announced on Monday that Morocco is negotiating with three more companies to acquire a COVID-19 vaccine as soon as one is available on the international market.


    October 20, 2020

    Octapharma announces FDA approval of updated NUWIQ® Prescribing Information to include immunogenicity data in previously untreated patients

    Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing Information (PI) for NUWIQ®, Octapharma’s human cell line-derived recombinant factor VIII (FVIII). NUWIQ ® is approved for the prevention and treatment of"...

    October 15, 2020

    COVID-19: Morocco Closes 229 Schools After Students, Staff Test Positive

    Rabat – Morocco’s Ministry of Education decided to close 229 schools across the country, serving a total of 12,599 students, after discovering COVID-19 cases among pupils, educators, and staff.


    October 15, 2020

    CNDH, KAS Seek Rights-Centered Reform of Morocco’s Health System

    Meknes – Morocco’s National Council of Human Rights (CNDH) and the Konrad Adenauer Foundation (KAS) launched on Wednesday a project to advance a human rights-centered reform of the country’s health system.


    October 15, 2020

    PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care

    PierianDx, the leading clinical genomics informatics company, and Pillar Biosciences, a leading next-generation sequencing clinical oncology company, today announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in combination with"...

    October 15, 2020

    GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

    GNT Pharma Inc. today reports positive top-line results from a phase II, double-blind, randomized, placebo-controlled, multi-center study assessing the safety and efficacy of nelonemdaz in acute ischemic stroke patients treated with endovascular thrombectomy within 8 hours of symptom onset (SONIC). In this study, the addition of nelonemdaz to surgical blood clot removal improved a patient’s chances of returning to functional independence 90 days later. Nelonemdaz is a moderate NR2B-selective N-methyl d-aspartate (NMDA) receptor antagonist and potent spin trapper that reduces NMDA receptor-mediated excitotoxicity and oxidative stress, two......

    October 14, 2020

    Morocco Creates Special COVID-19 PCR Test Unit for Police Officers

    Rabat – Morocco’s General Directorates of National Security and Territorial Surveillance (DGSN and DGST) have created a special unit to conduct COVID-19 PCR tests for police officers.

    The testin center"...

    October 14, 2020

    Boehringer Ingelheim and Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic

    Boehringer Ingelheim and Oxford BioTherapeutics Ltd. (OBT) today announced they are building on their successful partnership and are establishing a new alliance to discover additional selective targets for strategic cancer indications to deliver first-in-class treatments for cancer patients."...

    October 13, 2020

    Moroccan Military Hospital in Beirut Has Provided over 51,000 Medical Services So Far

    Beirut - The Moroccan military field hospital, set-up in Beirut following the high instructions of HM King Mohammed VI, has so far provided 51,223 medical services to the people affected by the tragic explosion which took place in the port of Beirut.


    October 12, 2020

    Morocco Signs Agreements to Achieve Universal Health Coverage by 2022

    Rabat – With the recent signing of two new partnership agreements, Morocco aims to achieve universal health coverage by 2022 and promote good standards and practices in terms of occupational health and safety.


    Stock Market






    9 209,87

    0,82 %

    9 135,23


    11 329,76

    0,81 %

    11 238,86


    10 269,41

    0,50 %

    10 218,62

    Found articles: - Pages  
    Contact US | © 2020 All Rights Reserved